European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-30

Proof Of Concept Use of MTH1 Inhibitors as New Treatments for cancer

Objetivo

"In our ERC grant GEnetic NEtworks as a tool for anti-CAncer Drug Development we used phenotypic screening and genetic networks to identify the DNA repair protein MTH1 as a critical component for cancer cell survival and we developed selective sub nM inhibitors to MTH1, which specifically kill cancer cells and tumours, whilst being less toxic to primary cells. Our approach provides a novel concept for treating cancer. Here, we want to explore the commercial potential of the MTH1 inhibitors identified in the ERC grant."

Convocatoria de propuestas

ERC-2013-PoC
Consulte otros proyectos de esta convocatoria

Institución de acogida

KAROLINSKA INSTITUTET
Aportación de la UE
€ 105 990,00
Dirección
Nobels Vag 5
17177 Stockholm
Suecia

Ver en el mapa

Región
Östra Sverige Stockholm Stockholms län
Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Jill Blomstrand (Mrs.)
Enlaces
Coste total
Sin datos

Beneficiarios (2)